Contract Manufacturing Services

Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

As part of the CPhI Festival of Pharma 2020, we brought together experts from our annual Power List to discuss the impact of COVID-19 on the industry.

Platinum group (and other precious) metal catalysts are inherently expensive, so why not recover and recycle?

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

How can companies avoid the risks of HPAPI containment and handling?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”